checkAd

Fortress Biotech Aktie

 
Smartbroker

Chart

Neuigkeiten

ZeitTitel
SmartbrokerSmartbroker: Ab 0€ pro Order handeln mit dem Testsieger (Finanztest 11/2020) Anzeige
19.04.21
Avatar pegasusorion schrieb:
07.04.21Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference
globenewswire | Weitere Nachrichten
05.04.21Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank
globenewswire | Weitere Nachrichten
01.04.21Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA
globenewswire | Weitere Nachrichten
31.03.21Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate Highlights
globenewswire | Weitere Nachrichten
22.03.21Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane for the Treatment of Severe Recalcitrant Nodular Acne
globenewswire | Weitere Nachrichten
04.03.21Fortress Biotech to Participate in Four March 2021 Virtual Investor Conferences
globenewswire | Weitere Nachrichten
26.02.21Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day
globenewswire | Weitere Nachrichten
24.02.21Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of the Zydus Group, Sign Development and Asset Purchase Agreement for Cyprium Therapeutics’ Copper Histidinate Product Candidate for Treatment of
globenewswire | Weitere Nachrichten
22.02.21Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
globenewswire | Weitere Nachrichten
26.01.21DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
Business Wire (engl.) | Weitere Nachrichten
25.01.21DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
Business Wire (engl.) | Weitere Nachrichten
22.01.21FBIO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021
Business Wire (engl.) | Weitere Nachrichten
05.01.21Fortress Biotech to Participate in Three January 2021 Virtual Investor Conferences
globenewswire | Weitere Nachrichten
Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Community

Aktienkurs

BörsenplatzNasdaq
Letzter Kurs3,060USD
Performance-2,86 %
Kurszeit24.07.21
Eröffnung3,120USD
Tageshoch3,150USD
Tagestief3,040USD
Vortageskurs3,150USD
Volumen287,72 Tsd.Stk.
52-Wochen Hoch6,100USD
52-Wochen Tief2,120USD
Anzahl Trades931
Performance 1 Monat-13,70 %
Performance 1 Jahr+6,06 %

Performance

ZeitKursPerf.
1 Tag3,060USD
-2,86 %
1 Woche3,080USD
+2,27 %
1 Monat3,650USD
-13,70 %
3 Monate4,270USD
-26,23 %
6 Monate3,540USD
-11,02 %
Lfd. Jahr3,170USD
-0,63 %
1 Jahr2,970USD
+6,06 %
3 Jahre2,530USD
+24,51 %
5 Jahre3,010USD
+4,65 %

Stammdaten

NameFortress Biotech Inc
KurznameFortress Biotch
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA14SJV
SymbolFBIO
BrancheBiotechnologie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl97,32 Mio.
Marktkapitalisierung297,80 Mio.USD

Kontaktdaten

NameFortress Biotech Inc
StadtNew York, NY
LandUSA USA

Aktionäre interessieren sich auch für:

#WertpapierPerf. %
1.-0,29
2.+0,97
3.-0,68
4.+0,65
5.0,00
 
6.+0,06
7.-19,66
8.+1,25
9.-2,62
10.+1,98